W Janni
Impact in
- Oncology top 10%
- Cancer Cells and Metastasis
- Bone health and treatments
- HER2/EGFR in Cancer Research
- Cancer Diagnosis and Treatment
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
Papers in ⓘ
- Oncology 58
- Cancer Treatment and Pharmacology 22
- Cancer Cells and Metastasis 21
- HER2/EGFR in Cancer Research 11
- Cancer Diagnosis and Treatment 7
-
- Advanced Breast Cancer Therapies 20
- Metastasis and carcinoma case studies 7
- Co-authors
- Klaus Pantel (17 shared papers)Harald Sommer (6 shared papers)Brigitte Rack (19 shared papers)Stephan Braun (3 shared papers)F. Hepp (4 shared papers)G. Riethmüller (1 shared paper)F Willgeroth (2 shared papers)Christian Schindlbeck (12 shared papers)
In The Last Decade
W Janni
63 papers receiving 437 citations
Peers
Comparison fields: 5 of 47
- Oncology 363
- Cancer Research 193
- Radiology, Nuclear Medicine and Imaging 86
- Pulmonary and Respiratory Medicine 119
- Pathology and Forensic Medicine 34
Countries citing papers authored by W Janni
This map shows the geographic impact of W Janni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W Janni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W Janni more than expected).
Fields of papers citing papers by W Janni
This network shows the impact of papers produced by W Janni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W Janni. The network helps show where W Janni may publish in the future.
Co-authors
The 25 scholars most cited alongside W Janni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Monoclonal antibody therapy with edrecolomab in breast cancer patients: monitoring of elimination of disseminated cytokeratin-positive tumor cells in bone marrow. | 1999 | 109 |
| 2 | 2010 | 64 | |
| 3 | 2009 | 55 | |
| 4 | 2001 | 26 | |
| 5 | 2008 | 21 | |
| 6 | 2016 | 20 | |
| 7 | 2004 | 13 | |
| 8 | 2011 | 12 | |
| 9 | 2001 | 11 | |
| 10 | 2011 | 11 | |
| 11 | 2005 | 6 | |
| 12 | 2012 | 5 | |
| 13 | 2011 | 5 | |
| 14 | 2003 | 5 | |
| 15 | 2009 | 4 | |
| 16 | 2010 | 4 | |
| 17 | 2003 | 4 | |
| 18 | 2009 | 4 | |
| 19 | 2009 | 4 | |
| 20 | 2009 | 4 |
About W Janni
W Janni is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 72 papers that have together received 449 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (29 papers), Cancer Treatment and Pharmacology (22 papers), Cancer Cells and Metastasis (21 papers), Advanced Breast Cancer Therapies (20 papers), HER2/EGFR in Cancer Research (11 papers), Metastasis and carcinoma case studies (7 papers), Cancer Diagnosis and Treatment (7 papers) and Cancer Genomics and Diagnostics (6 papers). The work is most often cited by research in Oncology (363 citations), Cancer Research (193 citations), Radiology, Nuclear Medicine and Imaging (86 citations), Pulmonary and Respiratory Medicine (119 citations) and Pathology and Forensic Medicine (34 citations). W Janni has collaborated with scholars based in Germany, France and Poland. Frequent co-authors include Klaus Pantel, Harald Sommer, Brigitte Rack, Stephan Braun, F. Hepp, G. Riethmüller, F Willgeroth, Christian Schindlbeck, Ulrich Andergassen and B. Strobl. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, European Journal of Cancer, The Breast and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.